Oct. 12 at 1:51 PM
$SYIN - I had written that I thought a wealthy individual was behind the funding for SynBio and I began searching for that article this weekend and couldn't find it.
So until I can, I'll retract that. I did find the following with a search.
"No shares issued: Synbio announced on August 25, 2025, that no shares had been issued to date from the SPA with Global Corporate Finance.
FacialDx funding: In October 2025, Synbio announced a new SPA with FacialDx, Inc. This included staged funding commitments over the following 12 months.
Focus on clinical trials: The August announcement stated that any new investment would be primarily used for the clinical feasibility trial for Synbio's facial analysis medtech. This was before the FacialDx agreement was finalized, which also emphasizes support for clinical trials.
While Global Corporate Finance was part of Synbio's strategy in August, the new agreements with FacialDx suggest that Synbio has pivoted to new partnerships for funding and operations."